Literature DB >> 8099484

L-triiodothyronine: is this peripheral hormone a central neurotransmitter?

G A Mason1, C H Walker, A J Prange.   

Abstract

L-triiodothyronine (T3) has previously been shown to enhance fast-phase, depolarization-induced 45Ca uptake and 3H-gamma-aminobutyric acid release by rat brain synaptosomes at low nanomolar concentrations comparable to those reported for whole brain. Nevertheless, the physiologic importance of these nonnuclear-mediated effects of T3 has remained uncertain, in part because specific mechanisms and the presence of T3 at presumptive sites of action have not been demonstrated. Isotopic studies showing that L-tetraiodothyronine (thyroxine T4) and T3 are concentrated in synaptosomes, and that T4 is deiodinated to T3 suggested that endogenous levels of T3 in nerve terminals are probably much higher than in other compartments of the brain. In the present study we confirmed that endogenous levels of T3 in nerve terminals are at least eightfold higher, and may be as much as 60-fold higher, than in whole brain. More importantly, we showed that both 125I-labeled T3 and endogenous T3, but not 125I-T4 or endogenous T4, are released from depolarized synaptosomes, primarily by a Ca(2+)-dependent process. This demonstrates a mechanism for raising the level of T3 within the synapse, where the hormone may interact with pre- and postsynaptic binding (or uptake) sites, and suggests that the peripheral hormone T3 may be a neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099484     DOI: 10.1038/npp.1993.28

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  7 in total

1.  The effects of hypothyroidism on 5-HT1A and 5-HT2A receptors and the serotonin transporter protein in the rat brain.

Authors:  A V Kulikov; R Jeanningro
Journal:  Neurosci Behav Physiol       Date:  2001 Jul-Aug

2.  Revisiting thyroid hormones in schizophrenia.

Authors:  Nadine Correia Santos; Patrício Costa; Dina Ruano; António Macedo; Maria João Soares; José Valente; Ana Telma Pereira; Maria Helena Azevedo; Joana Almeida Palha
Journal:  J Thyroid Res       Date:  2012-03-26

3.  Interactions of L-3,5,3'-Triiodothyronine [corrected], Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes.

Authors:  Thomas Westergard; Reza Salari; Joseph V Martin; Grace Brannigan
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 4.  Graves' disease and mental disorders.

Authors:  Atsushi Fukao; Junta Takamatsu; Takeshi Arishima; Mika Tanaka; Toshio Kawai; Yasuki Okamoto; Akira Miyauchi; Akihisa Imagawa
Journal:  J Clin Transl Endocrinol       Date:  2019-10-11

5.  Standards for thyroid laboratory testing, and cognitive functions after menopause.

Authors:  Iwona Bojar; Przemysław Bejga; Mariusz Witczak; Robert Łyszcz; Marta Makara-Studzinska
Journal:  Prz Menopauzalny       Date:  2014-09-09

6.  Mechanisms of L-triiodothyronine-induced inhibition of synaptosomal na(+)-k(+)-ATPase activity in young adult rat brain cerebral cortex.

Authors:  Pradip K Sarkar; Avijit Biswas; Arun K Ray; Joseph V Martin
Journal:  J Thyroid Res       Date:  2013-11-07

7.  L-3,3',5-triiodothyronine and pregnenolone sulfate inhibit Torpedo nicotinic acetylcholine receptors.

Authors:  Steven X Moffett; Eric A Klein; Grace Brannigan; Joseph V Martin
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.